Connecticut Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Hold |
11,520
| – | – | 0.01% | 297 |
|
|
2025
Q1 | $207K | Hold |
11,520
| – | – | 0.01% | 293 |
|
|
2024
Q4 | $194K | Hold |
11,520
| – | – | 0.01% | 264 |
|
|
2024
Q3 | $186K | Hold |
11,520
| – | – | 0.01% | 320 |
|
|
2024
Q2 | $94.7K | Hold |
11,520
| – | – | ﹤0.01% | 320 |
|
|
2024
Q1 | $170K | Hold |
11,520
| – | – | 0.01% | 320 |
|
|
2023
Q4 | $167K | Hold |
11,520
| – | – | 0.01% | 319 |
|
|
2023
Q3 | $124K | Hold |
11,520
| – | – | 0.01% | 289 |
|
|
2023
Q2 | $149K | Hold |
11,520
| – | – | 0.01% | 262 |
|
|
2023
Q1 | $152K | Buy |
11,520
+3,520
| +44% | +$46.5K | 0.01% | 244 |
|
|
2022
Q4 | $120K | Hold |
8,000
| – | – | 0.01% | 203 |
|
|
2022
Q3 | $94K | Hold |
8,000
| – | – | 0.01% | 189 |
|
|
2022
Q2 | $90K | Hold |
8,000
| – | – | 0.01% | 186 |
|
|
2022
Q1 | $239K | Buy |
+8,000
| New | +$239K | 0.02% | 165 |
|